检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:赵虹[1] 魏嘉平[1] 李耘[1] 汪家瑞[1] 高来顺[1] 曹丽娜[1] 刘淼[1]
机构地区:[1]首都医科大学宣武医院心内科,北京100053
出 处:《中国中西医结合急救杂志》2001年第6期367-369,共3页Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care
基 金:首都医科大学科研基金资助项目 ( No. 974994)
摘 要:目的 :评价普乐林注射液对急性心肌梗死患者梗死面积和心肌缺血总负荷的影响。方法 :将 10 2例急性心肌梗死患者随机分为普乐林治疗组和对照组 ,记录每例患者入院时和入院第 11日的血压、心率、12导联心电图及 2 4小时动态心电图 ,用 Wagner的 QRS记分法进行 QRS记分 ,预测梗死面积 ,计数有 Q波导联数(Qn)及 Q波总幅度 (ΣQ) ,计算 2 4小时心肌缺血总时间和缺血总负荷 ,并观察住院期间 (2~ 5周 )梗死后心绞痛及再闭塞的发生率。结果 :普乐林注射液治疗 11日后 ,降低心肌缺血总时间和缺血总负荷的幅度均较对照组增加 ,有 Q波导联数减少 ,Q波总幅度降低 ,梗死面积缩小 ,梗死后心绞痛的发生率较对照组低 ,再闭塞的发生率少于对照组。结论 :普乐林注射液有改善急性心肌梗死患者的心肌缺血状态。Objective:To determine the effects of Puerarin injection(普乐林注射液) on the infarct size and total ischemic burden in acute myocardial infarction patients.Methods:A singleblind randomized clinical trail was conducted in 102 patients with acute myocardial infarction who were given either Puerarin injection or not.The blood pressure,heart rate,electrocardiogram and Holter monitoring were recorded before therapy and 11 days after completion of the Puerarin injection therapy.The size of infarct with the method of Wagneris QRS scoring system was estimated and the leads with Q wave and the amplitude of Q wave was counted.The total ischemic time and burden were counted.The incidence of angina postinfarction and reinfarction in hospital were also observed.Results:After Puerarin injection therapy,the leads with Q wave and the total amplitude were decreased ,the infarct size and total ischemic burden were lower,the attacks of angina and reinfarction before discharge were also fewer than the controls.Conclusions:Puerarin injection therapy may improve myocardial ischemia after acute myocardial infarction,and prevent the extension of infarction size.
分 类 号:R542.22[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.177